IgG4相关性硬化性胆管炎的诊治现状

叶丹; 李国华

doi:10.3969/j.issn.1001-5256.2016.10.047

IgG4相关性硬化性胆管炎的诊治现状

DOI: 10.3969/j.issn.1001-5256.2016.10.047

叶丹,
李国华

南昌大学第一附属医院消化科

详细信息

中图分类号: R657.45
计量
- 文章访问数: 1366
- HTML全文浏览量: 14
- PDF下载量: 380
- 被引次数: 0
出版历程
- 出版日期: 2016-10-20

Current status of diagnosis and treatment of IgG4-related sclerosing cholangitis

Ye Dan,
Li GuoHua

Department of Gastroenterology, The Fist Affiliated Hospital of Nanchang University

摘要

摘要:
近年来国内外有不少关于IgG4相关性硬化性胆管炎诊断和治疗的报道,但由于病案少,目前展开的大规模临床对照试验甚少。归纳了有关IgG4相关性硬化性胆管炎诊断和治疗的相关文献,指出IgG4相关性硬化性胆管炎的诊断需结合全面的临床资料和病理检查,治疗主要依赖糖皮质激素和免疫抑制剂。
- 胆管炎,硬化性 /
- 诊断 /
- 治疗 /
- 综述
Abstract:
In recent years,many reports on the diagnosis and treatment of IgG4-related sclerosing cholangitis have been published in China and foreign countries,but due to the small number of cases,there are few large-scale controlled clinical trials. Therefore,this article reviews the literature on the diagnosis and treatment of IgG4-related sclerosing cholangitis and points out that the diagnosis of IgG4-related sclerosing cholangitis needs complete clinical data and comprehensive pathological examinations,and its treatment relies on glucocorticoids and immunosuppressants.
- cholangitis /
- sclerosing /
- diagnosis /
- therapy

HTML全文

参考文献(30)

[1]KAMISAWA T,FUNATA N,HAYASHI Y,et al.A new clinicopathological entity of Ig G4-related autoimmune disease[J].J Gastroenterol,2003,38(10):982-984.

[2]BJRNSSON E,CHARI ST,SMYRK TC,et al.Immunoglobulin G4 associated cholangitis:description of an emerging clinicaentity based on review of the literanlre[J].Hepatology,2007,45(6):1547-1554.

[3]BEUERS U,BOBERG KM,CHAPMAN RW,et al.EASL clinical practice guidelines:management of cholestatic liver diseases[J].J Hepatol,2009,51(2):237-267.

[4]CHAPMAN R,FEVERY J,KALLOO A,et al.Diagnosis and management of primary sclerosing cholangitis[J].Hepatology,2010,51(2):660-678.

[5]ZEN Y,KAWAKAMI H,KIM JH.Ig G4-related sclerosing cholangitis:all we need to know[J].J Gastroenterol,2016,51(4):295-312.

[6]CHARI ST,SMYRK TC,LEVY MJ,et al.Diagnosis of autoimmune pancreatitis:the Mayo Clinic experience[J].Clin Gastroenterol Hepatol,2006,4(8):1010-1016.

[7]NAKAZAWA T,ANDO T,HAYASHI K,et al.Diagnostic procedures for Ig G4-related sclerosing cholangitis[J].J Hepatobiliary Pancreat Sci,2011,18(2):127-136.

[8]OHARA H,OKAZAKI K,TSUBOUCHI H,et al.Clinical diagnostic criteria of Ig G4-related sclerosing cholangitis 2012[J].J Hepatobiliary Pancret Sci,2012,19(5):536-542.

[9]LI P,LI YZ.Progress in diagnosis and treatment of Ig G4-related hepatobiliary diseases[J].J Clin Hepatol,2014,30(5):396-399.(in Chinese)李萍,李永哲.Ig G4相关肝胆疾病诊疗进展[J].临床肝胆病杂志,2014,30(5):396-399.

[10]ZHANG YA,SHEN XZ,ZHU JM,et al.Extensive metastatic cholangiocarcinoma associated with Ig G4-related sclerosing cholangitis misdiagnosed as isolated Ig G4-related sclerosing cholangitis:a case report and literature review[J].Medicine(Baltimore),2015,94(45):1-8.

[11]WANG NN,SUN MJ.Ig G4-related sclerosing cholangitis complicated by autoimmune pancreatitis:a clinical analysis of 8 cases[J].Shandong Med J,2015,55(8):43-45.(in Chinese)王宁宁,孙明军.Ig G4相关硬化性胆管炎并自身免疫性胰腺炎8例临床分析[J].山东医药,2015,55(8):43-45.

[12]NOVOTNY I,DT EP,TRMA J,et al.Immunoglobulin G4-related cholangitis:a variant of Ig G4-related systemic disease[J].Dig Dis,2012,30(2):216-219.

[13]NAITOH I,NAKAZAWA T,HAYASHI K,et al.Comparison of intraductal ultrasonography findings between primary sclerosing cholangitis and Ig G4-related sclerosing cholangitis[J].J Gastroenterol Hepatol,2015,30(6):1104-1109.

[14]ZEN Y,BRITTON D,MITRA V,et al.A global proteomic study identifies distinct pathological features of Ig G4-related and primary sclerosing cholangitis[J].Histopathology,2016,68(6):796-809.

[15]YIN DL,LIU LX,JIANG HC.Advances in diagnosis and treatment of Ig G4-related cholangitis[J].Chin J Pract Surg,2016,34(12):1194-1196.(in Chinese)尹大龙,刘连新,姜洪池.Ig G4相关胆管炎诊治进展[J].中国实用外科杂志,2016,34(12):1194-1196.

[16]XU BL,TU CT.A case report of Ig G4-related sclerosing cholangitis[J].J Clin Hepatol,2015,31(11):1910-1911.(in Chinese)徐蓓莉,涂传涛.Ig G4相关性硬化性胆管炎1例报告[J].临床肝胆病杂志,2015,31(11):1910-1911.

[17]NAVANEETHAN U,GUTIERREZ NG,JEGADEESAN R,et al.Ig G4 levels in bile for distinguishing Ig G4-associated cholangiopathy from other biliary disorders:a single blinded pilot study[J].Clin Endosc,2014,47(6):555-559.

[18]SAH RP,CHARI ST.Autoimmune pancreatitis:an update on classification,diagnosis,natural history and management[J].Curr Gastroenterol Rep,2012,14(2):95-105.

[19]HART PA,TOPAZIAN MD,WITZIG TE,et al.Treatment of relapsomg autoimmune pancreatitis with immunomodulators and rituximab:the Mayo Clinic experience[J].Gut,2013,62(1):1606-1615.

[20]KHOSROSHAHI A,STONE JH.Treatment approaches to Ig G4-related systemic disease[J].Curr Opin Rheumatol,2010,23(1):67-71.

[21]TOMIYAMA T,UCHIDA K,MASUSHITA M,et al.Comparison of steroid pulse therapy and conventional oral steroid therapy as initial threatment for autoimmune pancretitis[J].J Gastroenterol,2011,46(5):696-704.

[22]IWASAKI S,KAMISAWA T,KOIZUMI S,et al.Assessment in steroid trial for Ig G4-related sclerosing cholangitis[J].Adv Med Sci,2015,60(2):211-215.

[23]YOU MW,KIM JH,BYUN JH,et al.Relapse of Ig G4-related sclerosing cholangitis after steroid therapy:image findings and risk factors[J].Eur Radiol,2014,24(5):1039-1048.

[24]CLENDENON JN,ARANDA-MICHEL J,KRISHNA M,et al.Recurrent liver failure caused by Ig G4 associated cholangitis[J].Ann Hepatol,2011,10(4):562-564.

[25]KHOSROSHAHI A,CARRUTHERS MN,DESHPANDE V,et al.Rituximab for the treatment of Ig G4-related disease:lessons from10 consecutive patients[J].Medicine,2012,91(1):57-66.

[26]KHOSROSHAHI A,BLOCH DB,DESHPANDE V,et al.Rituximab theraphy leads to rapid decline of serum Ig G4 levels and prompt clinical improvenment in Ig G4-related systemic disease[J].Arthritis Rheum,2010,62(6):1755-1762.

[27]MA YM,SHANG LH,CHEN HG.Clinical effect of integrated traditional Chinese and Western medicine therapy in treatment of Ig G4-related cholangitis:an analysis of 36 cases[J].Jiangxi Chin Med,2015,46(396):42-44.(in Chinese)马悦茗,尚龙华,陈惠根.中西医结合治疗Ig G4相关性胆管炎36例[J].江西中医药,2015,46(396):42-44.

[28]ZHANG J,LI B,LI F,et al.Clinical effect of integrated traditional Chinese and Western medicine therapy in treatment of primary sclerosing cholangitis[J].Mod J Integr Tradit Chin West Med,2013,22(28):3132-3133.(in Chinese)张健,李冰,李梵,等.中西医结合治疗原发性硬化性胆管炎疗效观察[J].现代中西医结合杂志,2013,22(28):3132-3133.

[29]CHENG LP,FU J,GENG L,et al.Ig G4-related sclerosing cholangitis:a case report and literature review[J].J Hepatobiliary Surg,2015,23(2):117-120.(in Chinese)程利鹏,付军,耿利,等.Ig G4相关硬化性胆管炎一例并国内文献复习[J].肝胆外科杂志,2015,23(2):117-120.

[30]KHOSROSHAHI A,WALLACE ZS,CROWE JL,et al.International consensus guidance statement on the management and treatment of Ig G4-related disease[J].Arthritis Rheum,2015,67(7):1688-1699.

施引文献

资源附件(0)

访问统计